TICKER INTELLIGENCE
$CRL is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 2 active Congressional signals mentioning $CRL, including 2 bills. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.
$CRL is currently facing 2 active congressional signals tracked by HillSignal. With 0 bullish, and 2 bearish signals, covering 1 sector. Key sectors affected include Healthcare. Recent major catalysts include CARGO Act of 2025 and To amend section 495 of the Public Health Service Act to require inspections of foreign laboratories conducting biomedical and behavioral research to ensure compliance with applicable animal welfare requirements, and for other purposes.. Below is the complete tracker of government activity affecting $CRL’s market performance.
2
Total Signals
Active
Action Status
0
Bullish Signals
2
Bearish Signals
The CARGO Act of 2025, an early-stage Senate bill, would ban NIH funding for animal research conducted outside the U.S., redirecting $2.2B from international to domestic facilities. Over the past 7 days, $CRL has fallen -2.88% and $IQV has fallen -1.6%, reflecting the market pricing in this legislative headwind for CROs with international exposure.
HR7165 (WATCH Act) imposes quarterly inspection mandates on foreign labs conducting NIH-funded animal research, targeting CROs like IQVIA and CRL. Both stocks have declined sharply in the last week, with IQVI down 2.49% and CRL down 3.4% over 7 days, reflecting sector weakness amplified by this regulatory overhang. The bill is early-stage and authorized no new funding, but its compliance costs would pressure margins if enacted.
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →